In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 61 for your search:
Cancer Type/Condition:  BRCA1 mutation carrier
Stage/Subtype:  BRCA1 mutation carrier
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Screening
Status: Active
Age: 25 to 70
Sponsor: Other
Protocol IDs: DBCG07MRBRCA, NCT00413491

2.

Phase: Phase III, Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: BREC-AGC, NCT01206218

3.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 69
Sponsor: Other
Protocol IDs: UC-0104/0701 - ONCO03, ONCO-03/0701, EU-20806, NOVARTIS-FNCLCC-ONCO 03/0701, 2007-000687-24, FNCLCC-ONCO-03/0701, FNCLCC-ONCO 03/0701 - LIBER, NCT00673335

4.

Phase: Phase III
Type: Prevention
Status: Active
Age: 20 to 46
Sponsor: Other
Protocol IDs: IEO S462/109, 2009-010260-41, NCT01479192

5.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 11-001687, NCT01591746

6.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: N12OLG, 2012-000838-19, NCT01646034

7.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PR-30-5011-C, NCT01847274

8.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention, Treatment
Status: Approved-not yet active
Age: 25 to 55
Sponsor: NCI, Other
Protocol IDs: A211102, U10CA031946, NCI-2013-00995, NCT01905046

9.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PR-30-5010-C, 1307-BCG, NCT01905592

10.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 673-301, NCT01945775

11.

Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D0819C00003, 2013-005137-20, NCT02000622

12.

Phase: Phase III
Type: Natural history/Epidemiology, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D081CC00006, BIG 6-13, NSABP B-55, NCT02032823

13.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Veli-BRCA, NCT01472783

14.

Phase: Phase II
Type: Prevention
Status: Active
Age: 30 to 90
Sponsor: Other
Protocol IDs: 102/07 (HT4351), NCT00496288

15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 50
Sponsor: NCI, Other
Protocol IDs: S0812, U10CA037429, NCI-2011-02032, SWOG-S0812, NCT01097278

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 21 to 49
Sponsor: Other
Protocol IDs: 12377, NCT01276704

17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: M12-895, 2011-002913-12, NCT01506609

18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-00864, CDR0000732189, MSKCC-12-045, IRB #12-045, 8993, N01CM00032, N01CM00071, U01CA069856, P30CA008748, 12-045, NCT01585805

19.

Phase: Phase II
Type: Treatment
Status: Active
Age: 20 to 70
Sponsor: Other
Protocol IDs: BN-001/83/07-B, NCT01630226

20.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 673-201, NCT02034916

21.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01472, CINJ-050810, CDR0000641433, U01CA062505, UPCI 08-121, U01CA099168, 08-121, 8282, P30CA047904, NCT00892736

22.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 25 to 45
Sponsor: Other
Protocol IDs: 2009-015-B, NCT01022333

23.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Screening
Status: Active
Age: 25 to 80
Sponsor: Other
Protocol IDs: P50CA83636-01, 6973, NCT01121640

24.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 110022, 11-C-0022, NCT01237067

25.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-03458, CDR0000710900, DFCI-11-144, 11-144, 8484, P30CA006516, R01CA090687, U01CA062490, NCT01434316
1    
New Search